StockData
CVS HEALTH Corp logo

CVS HEALTH Corp (CVS) operating KPIs

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$90.25−0.08 (-0.09%)

Close on Oct 30, 2026Market cap $115.43BP/E 23.9Yield 2.95%

Cvs Health aFS Debt Securities — Gross Unrealized Gains ($M)

Quarterly figures from Cvs Health's filings and investor materials

QuarterlyAnnual
Latest, Q2 2026
207
Period ended Jun 30, 2026
Change on a year earlier
-40.3%
347 in Q2 2025
History
30 quarters
Since Q4 2018
Sources
2
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAFS Debt Securities — Gross Unrealized Gains ($M)Year on yearSource
Q2 2026Jun 30, 2026207-40.3%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q1 2026Mar 31, 2026245-0.4%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q4 2025Dec 31, 2025449+152.2%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q3 2025Sep 30, 2025462-9.4%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q2 2025Jun 30, 2025347+137.7%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q1 2025Mar 31, 2025246+28.8%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q4 2024Dec 31, 2024178-33.3%CVS SEC 10-K (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q3 2024Sep 30, 2024510+1,357.1%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q2 2024Jun 30, 2024146+111.6%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q1 2024Mar 31, 2024191+89.1%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q4 2023Dec 31, 2023267+368.4%CVS SEC 10-K (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q3 2023Sep 30, 202335+34.6%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q2 2023Jun 30, 202369+6.2%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q1 2023Mar 31, 2023101-76.4%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q4 2022Dec 31, 202257-95.1%CVS SEC 10-K (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗
Q3 2022Sep 30, 202226-98.0%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax) ↗

Cite this data

StockData. (2026). Cvs Health AFS Debt Securities — Gross Unrealized Gains ($M), quarterly Q4 2018–Q2 2026 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/inv_afs_unreal_gain

See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.